aDivision of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio

bDivision of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA

cDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio

dMolecular Therapeutics Section, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Correspondence to Eric A. Singer, MD, MA, MS, FACS, FASCO, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. E-mail: [email protected]